Editorial: the role for PIVKA‐II measurement after HCV elimination by direct‐acting anti‐virals in terms of prediction of hepatocellular carcinoma

Editorial: the role for PIVKA‐II measurement after HCV elimination by direct‐acting anti‐virals in terms of prediction of hepatocellular carcinoma

LINKED CONTENT This article is linked to Degasperi et al papers. To view these articles, visit https://doi.org/10.1111/apt.16685 and https://doi.org/10.1111/apt.16710

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2022-01, Vol.55 (1), p.122-123
1. Verfasser: Ogawa, Eiichi
Format: Artikel
Sprache:eng
Schlagworte:
Biomarkers
Carcinoma, Hepatocellular - drug therapy
Hepatitis C - drug therapy
Hepatocellular carcinoma
Humans
Liver Neoplasms
Protein Precursors
Prothrombin
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:LINKED CONTENT This article is linked to Degasperi et al papers. To view these articles, visit https://doi.org/10.1111/apt.16685 and https://doi.org/10.1111/apt.16710
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.16696